Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
REFERENCES Expert Panel Report 3, “Guidelines for the Diagnosis and Management of Asthma,” Clinical Practice Guidelines , National Institutes of Health, National Heart, Lung, and Blood Institute, NIH Publication No. 08-4051, prepublication 2007. Available at file://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm Pohunek P, Kuna P, Jorup C, et al, “Budesonide/Formoterol Improved Lung Function Compared With Budesonide Alone in Children With Asthma,” Pediatr Allergy Immunol , 2006, 17(6):458-65. [PubMed 16925692 ] Rennard SI, Tashkin DP, McElhattan J, et al, “Long-Term Efficacy of Budesonide/Formoterol Administered Via One Pressurized Metered-Dose Inhaler in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease [poster],” Chest , 2008, 134:103001S. Rennard SI, Tashkin DP, McElhatta J, et al, “Long-Term Tolerability of Budesonide and Formoterol Administered in One Pressurized Metered-Dose Inhaler in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease,” Chest , 2008, 134:103003S. Tashkin DP, Rennard SI, Martin P, et al, “Efficacy of Budesonide/Formoterol Administered Via One Pressurized Metered-Dose Inhaler Over 6 Months in Patients With Chronic Obstructive Pulmonary Disease,” Chest , 2008, 134:105001S. Topic 8524 Version 44.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0504-61.55.141.10-629A639819-S244013.14]